Cargando…
Neutrophil-to-lymphocyte ratio is associated with 28-day mortality in patients with severe fever with thrombocytopenia syndrome
OBJECTIVES: To determine the association of the neutrophil-to-lymphocyte ratio (NLR) with 28-day mortality in patients with severe fever with thrombocytopenia syndrome (SFTS). METHODS: A single-centre retrospective analysis was performed in an emergency department from January 01, 2018, to June 30,...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898529/ https://www.ncbi.nlm.nih.gov/pubmed/35249544 http://dx.doi.org/10.1186/s12879-022-07206-8 |
_version_ | 1784663672880103424 |
---|---|
author | Liu, Yun Ni, Jun Xiong, Yali Wu, Chao He, Fei |
author_facet | Liu, Yun Ni, Jun Xiong, Yali Wu, Chao He, Fei |
author_sort | Liu, Yun |
collection | PubMed |
description | OBJECTIVES: To determine the association of the neutrophil-to-lymphocyte ratio (NLR) with 28-day mortality in patients with severe fever with thrombocytopenia syndrome (SFTS). METHODS: A single-centre retrospective analysis was performed in an emergency department from January 01, 2018, to June 30, 2021. Univariate and multivariable Cox proportional hazards regression models were used to investigate the prognostic factors associated with 28-day mortality. Kaplan–Meier curves were analysed in patients stratified by the optimal cut-off point of the NLR determined using a receiver operating characteristic (ROC) curve. RESULTS: In total, 182 SFTS patients were included, and 24 (13.2%) died within 28 days. The median age of the included patients was 59.64 ± 12.74 years, and 48.4% (88/182) were male. The patients in the non-survival group had significantly higher NLRs than those in the survival group (6.91 ± 6.73 vs. 2.23 ± 1.83). The NLR was a significant predictor of 28-day mortality (adjusted HR: 1.121, 95% CI: 1.033, 1.215). The area under the ROC curve of the NLR for predicting 28-day mortality was 0.743 (95% CI: 0.624, 0.862), and the optimal cut-off value was 4.19 (sensitivity, 54.2%; specificity, 89.2%). In addition, 28-day mortality in the patients with an NLR ≥ 4.19 was notably higher than that in the patients with an NLR < 4.19 (43.3% vs. 7.2%), and Kaplan–Meier analysis showed that the patients with an NLR ≥ 4.19 had a significantly lower survival rate than those with an NLR < 4.19. CONCLUSIONS: The NLR was a significant, independent predictor of 28-day mortality in SFTS patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07206-8. |
format | Online Article Text |
id | pubmed-8898529 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-88985292022-03-17 Neutrophil-to-lymphocyte ratio is associated with 28-day mortality in patients with severe fever with thrombocytopenia syndrome Liu, Yun Ni, Jun Xiong, Yali Wu, Chao He, Fei BMC Infect Dis Research OBJECTIVES: To determine the association of the neutrophil-to-lymphocyte ratio (NLR) with 28-day mortality in patients with severe fever with thrombocytopenia syndrome (SFTS). METHODS: A single-centre retrospective analysis was performed in an emergency department from January 01, 2018, to June 30, 2021. Univariate and multivariable Cox proportional hazards regression models were used to investigate the prognostic factors associated with 28-day mortality. Kaplan–Meier curves were analysed in patients stratified by the optimal cut-off point of the NLR determined using a receiver operating characteristic (ROC) curve. RESULTS: In total, 182 SFTS patients were included, and 24 (13.2%) died within 28 days. The median age of the included patients was 59.64 ± 12.74 years, and 48.4% (88/182) were male. The patients in the non-survival group had significantly higher NLRs than those in the survival group (6.91 ± 6.73 vs. 2.23 ± 1.83). The NLR was a significant predictor of 28-day mortality (adjusted HR: 1.121, 95% CI: 1.033, 1.215). The area under the ROC curve of the NLR for predicting 28-day mortality was 0.743 (95% CI: 0.624, 0.862), and the optimal cut-off value was 4.19 (sensitivity, 54.2%; specificity, 89.2%). In addition, 28-day mortality in the patients with an NLR ≥ 4.19 was notably higher than that in the patients with an NLR < 4.19 (43.3% vs. 7.2%), and Kaplan–Meier analysis showed that the patients with an NLR ≥ 4.19 had a significantly lower survival rate than those with an NLR < 4.19. CONCLUSIONS: The NLR was a significant, independent predictor of 28-day mortality in SFTS patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07206-8. BioMed Central 2022-03-06 /pmc/articles/PMC8898529/ /pubmed/35249544 http://dx.doi.org/10.1186/s12879-022-07206-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Liu, Yun Ni, Jun Xiong, Yali Wu, Chao He, Fei Neutrophil-to-lymphocyte ratio is associated with 28-day mortality in patients with severe fever with thrombocytopenia syndrome |
title | Neutrophil-to-lymphocyte ratio is associated with 28-day mortality in patients with severe fever with thrombocytopenia syndrome |
title_full | Neutrophil-to-lymphocyte ratio is associated with 28-day mortality in patients with severe fever with thrombocytopenia syndrome |
title_fullStr | Neutrophil-to-lymphocyte ratio is associated with 28-day mortality in patients with severe fever with thrombocytopenia syndrome |
title_full_unstemmed | Neutrophil-to-lymphocyte ratio is associated with 28-day mortality in patients with severe fever with thrombocytopenia syndrome |
title_short | Neutrophil-to-lymphocyte ratio is associated with 28-day mortality in patients with severe fever with thrombocytopenia syndrome |
title_sort | neutrophil-to-lymphocyte ratio is associated with 28-day mortality in patients with severe fever with thrombocytopenia syndrome |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898529/ https://www.ncbi.nlm.nih.gov/pubmed/35249544 http://dx.doi.org/10.1186/s12879-022-07206-8 |
work_keys_str_mv | AT liuyun neutrophiltolymphocyteratioisassociatedwith28daymortalityinpatientswithseverefeverwiththrombocytopeniasyndrome AT nijun neutrophiltolymphocyteratioisassociatedwith28daymortalityinpatientswithseverefeverwiththrombocytopeniasyndrome AT xiongyali neutrophiltolymphocyteratioisassociatedwith28daymortalityinpatientswithseverefeverwiththrombocytopeniasyndrome AT wuchao neutrophiltolymphocyteratioisassociatedwith28daymortalityinpatientswithseverefeverwiththrombocytopeniasyndrome AT hefei neutrophiltolymphocyteratioisassociatedwith28daymortalityinpatientswithseverefeverwiththrombocytopeniasyndrome |